ALNY
$165.04+5.36%
as of close, Nov 13, 2026
☾ AH $165.04 +5.36%
Head-to-head:Compare with VRTX or any ticker →
Alnylam Pharmaceuticals Inc. total returns by year (including dividends)
As of market close, Nov 13, 2026
Every year since 2004#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $397.65 | $165.04 | 0.0% | -58.5% | |
| 2025 | $235.31 | $397.65 | 0.0% | +69.0% | |
| 2024 | $191.41 | $235.31 | 0.0% | +22.9% | |
| 2023 | $237.65 | $191.41 | 0.0% | -19.5% | |
| 2022 | $169.58 | $237.65 | 0.0% | +40.1% | |
| 2021 | $129.97 | $169.58 | 0.0% | +30.5% | |
| 2020 | $115.17 | $129.97 | 0.0% | +12.9% | |
| 2019 | $72.91 | $115.17 | 0.0% | +58.0% | |
| 2018 | $127.05 | $72.91 | 0.0% | -42.6% | |
| 2017 | $37.44 | $127.05 | 0.0% | +239.3% | |
| 2016 | $94.14 | $37.44 | 0.0% | -60.2% | |
| 2015 | $97.00 | $94.14 | 0.0% | -2.9% | |
| 2014 | $64.30 | $97.00 | 0.0% | +50.9% | |
| 2013 | $18.25 | $64.30 | 0.0% | +252.3% | |
| 2012 | $8.15 | $18.25 | 0.0% | +123.9% | |
| 2011 | $9.86 | $8.15 | 0.0% | -17.3% | |
| 2010 | $17.62 | $9.86 | 0.0% | -44.0% | |
| 2009 | $24.73 | $17.62 | 0.0% | -28.8% | |
| 2008 | $29.08 | $24.73 | 0.0% | -15.0% | |
| 2007 | $21.40 | $29.08 | 0.0% | +35.9% | |
| 2006 | $13.32 | $21.40 | 0.0% | +60.7% | |
| 2005 | $7.47 | $13.32 | 0.0% | +78.3% | |
| 2004since Jun 1 | $7.00 | $7.47 | 0.0% | +6.7% |
- Annualized
- +14.8%
- 2005–2026
- Average year
- +40.2%
- 21 full years
- Best year
- +252.3%
- 2013
- Worst year
- -60.2%
- 2016
- Positive years
- 13/21
- 62% up
Annualized (CAGR)
+14.8%
2005–2026
Average year
+40.2%
21 full years
Best year
+252.3%
2013
Worst year
-60.2%
2016
Positive years
13/21
62% up
Total return by period#
Annual
−300%−200%−100%0%100%200%300%
2004, since Jun 1+6.7%'04
2005+78%
2006+61%'06
2007+36%
2008-15%'08
2009-29%
2010-44%'10
2011-17%
2012+124%'12
2013+252%
2014+51%'14
2015-2.9%
2016-60%'16
2017+239%
2018-43%'18
2019+58%
2020+13%'20
2021+30%
2022+40%'22
2023-19%
2024+23%'24
2025+69%
2026-58%'26
Methodology#
Total returns, dividends reinvested, measured on ALNY. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Alnylam Pharmaceuticals Inc.'s average annual return?
- Since 2005, Alnylam Pharmaceuticals Inc. (ALNY) has returned about 14.8% a year (the compound annual growth rate) and an average calendar-year return of 40.2%.
- What were Alnylam Pharmaceuticals Inc.'s best and worst years?
- Over 2005–2026, the best year was 2013 (+252.3%) and the worst was 2016 (-60.2%).
- How often is Alnylam Pharmaceuticals Inc. up in a year?
- 13 of the 21 full years since 2005 were positive — about 62% of the time.
More on Alnylam Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with VRTX or any ticker →